Hylios
HomeIntelligencePricingResourcesNews
LoginFree daily briefStart a Pilot
Back to Intelligence

#generic-drug-tariffs

(3 articles)
Trade Policy & Tariffs
High ImpactAug 20, 2026

Trump's 2028 Generic Drug Tariff Proposal: Supply Chain Implications

The Trump administration's proposed tariff on generic drugs targeting 2028 represents a significant policy shift that could reshape pharmaceutical supply chains and pricing dynamics. While framed as a

Vinanet#generic-drug-tariffs#trade-policy#pharmaceutical-supply-chain
Trade Policy & Tariffs
High ImpactAug 19, 2026

Generic Drug Tariffs: Trump Plan Aims to Reshore US Production

The Trump administration has proposed targeted tariffs on generic drug imports as part of a broader industrial policy to reshore pharmaceutical manufacturing capacity to the United States. While the g

Vinanet#generic-drug-tariffs#pharmaceutical-reshoring#supply-chain-policy
Trade Policy & Tariffs
High ImpactAug 4, 2026

Trump's Generic Drug Tariffs Threaten Medicine Prices and Supply

The Trump administration's proposal to impose tariffs on generic drugs represents a significant structural shift in how the US pharmaceutical supply chain operates. Generic drugs, which represent roug

CNBC#generic-drug-tariffs#pharmaceutical-supply-chain#trump-trade-policy

Hylios

Hylios - Better Decisions. Made Faster.

Newsletter

The daily supply chain brief, free. Unsubscribe any time.

Product

  • Features
  • Shipper Network Diagnostic
  • Deal Intelligence
  • Demand Intelligence
  • For Carriers
  • Tariff Exposure
  • Pricing
  • Design Partners
  • Documentation

Guides

  • Digital Twin Guide
  • Simulation Guide
  • Modeling Guide
  • Sandbox Guide
  • Intelligence Buyer's Guide
  • Hylios vs Alternatives
  • Methodology

Company

  • About
  • News
  • Careers

Legal

  • Privacy Policy
  • Terms of Service
© 2026 Hylios. All rights reserved.